An Open-Label, Repeat-Dose, Single-Sequence Study to Investigate the Effects of Once-Daily Repeat Oral Administration of GW876008 125mg on the Pharmacokinetics of the Combined Oral Contraceptive in Female Volunteers.

Trial Profile

An Open-Label, Repeat-Dose, Single-Sequence Study to Investigate the Effects of Once-Daily Repeat Oral Administration of GW876008 125mg on the Pharmacokinetics of the Combined Oral Contraceptive in Female Volunteers.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs Emicerfont; Oral contraceptives
  • Indications Anxiety disorders; Depression; Irritable bowel syndrome; Pregnancy
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 20 May 2009 Actual initiation date changed from Feb 2007 to Jun 2007 as reported by ClinicalTrials.gov.
    • 19 Jun 2008 Status changed from recruiting to discontinued according to ClinicalTrials.gov record.
    • 03 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top